Drugs / Fibrin Pad
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01902459 Comparator | Jul 2013 → Aug 2015 | hemorrhagic disease | Ethicon, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibrin Pad | “EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis” NCT01902459 ↗ |
| Known as | EVARREST Fibrin Sealant Patch | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01902459 ↗ |
| Modality | Protein / enzyme biologic | “two biological components (human plasma-derived fibrinogen and thrombin) embedded in a flexible composite patch component” NCT01902459 ↗ |